Cheaper Alternatives to MEDVi: GLP-1 Providers Compared in 2026

Last reviewed: September 11, 2026 Last updated: September 11, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

MEDVi charges $299 per month for ongoing compounded semaglutide injection and $399 per month for ongoing compounded tirzepatide after an introductory first month (verified September 4, 2026; medvi.com). Several telehealth providers offer the same compounded GLP-1 medications at lower monthly rates. PlexusDx charges $189 per month for semaglutide injection and $289 per month for tirzepatide injection on month-to-month terms, no membership fee, dose increases included. Over twelve months that difference produces savings of $1,200 on semaglutide and $1,200 on tirzepatide compared to MEDVi's ongoing rates (our calculation). MEDVi's documented strengths include longer commitment ladders to forty-eight weeks, 0% financing through Klarna, unlimited doctor calls, and a free dietitian visit—advantages that may justify the higher ongoing rate for patients who value extended support and flexible payment terms.

At-a-glance comparison: MEDVi vs. alternatives

All figures verified September 4–11, 2026 from provider websites and checkout flows. MEDVi introductory first-month rates shown for reference; ongoing refill rate is the standard monthly cost from month two forward.

Like-for-like pricing: ongoing monthly rates

MEDVi advertises an introductory first-month rate of $179 for compounded semaglutide injection and $279 for compounded tirzepatide, then charges $299 per month and $399 per month respectively from the second month onward (verified September 4, 2026; medvi.com). The ongoing refill rate is the true recurring cost. MEDVi includes medication, clinician care, and shipping in that monthly price, with no separate membership fee (verified September 4, 2026; medvi.com).

PlexusDx charges $189 per month for compounded semaglutide injection and $289 per month for compounded tirzepatide injection on month-to-month terms, with no introductory discount and no membership fee (verified September 11, 2026; plexusdx.com). The published rate is the same every month, and dose increases do not change the price. PlexusDx also offers commitment tiers: $169 per month on a three-month commitment and $149 per month on a six-month commitment for semaglutide; $269 per month on three months and $249 per month on six months for tirzepatide (verified July 20, 2026; plexusdx.com).

Twelve-month cost comparison

Comparing month-to-month terms over twelve months shows the cumulative difference:

Compounded semaglutide injection:

• MEDVi: $179 (introductory first month) + $299 × 11 months = $3,468 total, or $289 per month average (our calculation)
• PlexusDx: $189 × 12 months = $2,268 total, or $189 per month (our calculation)
• Difference: $1,200 lower on PlexusDx over twelve months, or $100 per month average savings (our calculation)

Compounded tirzepatide injection:

• MEDVi: $279 (introductory first month) + $399 × 11 months = $4,668 total, or $389 per month average (our calculation)
• PlexusDx: $289 × 12 months = $3,468 total, or $289 per month (our calculation)
• Difference: $1,200 lower on PlexusDx over twelve months, or $100 per month average savings (our calculation)

On six-month commitment terms, PlexusDx charges $149 per month for semaglutide (six months = $894 total) and $249 per month for tirzepatide (six months = $1,494 total), both figures our calculation. MEDVi offers three-, six-, and twelve-month bundles with 0% financing through Klarna; however, published per-month rates for those bundles were not captured in this comparison, and multi-month bundles are non-refundable for unused months (verified July 20, 2026; plexusdx.com).

Oral routes and additional route charges

MEDVi offers compounded semaglutide in both injection and tablet form. The oral tablet option carries a $70 surcharge over the injection price, making the first month $249 and ongoing months $369 (verified September 4, 2026; medvi.com). MEDVi also lists compounded tirzepatide in both injection and oral routes; no separate oral surcharge was displayed for tirzepatide (verified September 4, 2026; medvi.com).

PlexusDx offers oral semaglutide capsules at $289 per month month-to-month, $269 per month on a three-month commitment, and $249 per month on a six-month commitment—substantially lower than MEDVi's $369 ongoing rate for semaglutide tablet (verified September 11, 2026; plexusdx.com). PlexusDx oral tirzepatide capsules are priced at $349 per month month-to-month, $299 per month on three months, and $279 per month on six months (verified September 11, 2026; plexusdx.com).

What MEDVi includes in its monthly rate

MEDVi's monthly price covers medication, clinician care, and shipping, with no separate membership fee (verified September 4, 2026; medvi.com). Documented included services are:

• Free care coaching: ongoing coaching at no additional charge (verified July 20, 2026; plexusdx.com)
• Free dietitian visit: one consultation included (verified July 20, 2026; plexusdx.com)
• Unlimited doctor calls: no limit on clinician consultations (verified July 20, 2026; plexusdx.com)
• Dose increases included: increases in medication dose do not raise the monthly price (verified September 4, 2026; medvi.com)
• 0% financing available: three-, six-, and twelve-month bundles can be paid in Klarna installments spread over twelve months at 0% interest (verified July 20, 2026; plexusdx.com)

MEDVi also offers a forty-eight-week (twelve-month) commitment bundle—the longest prepaid term documented among telehealth GLP-1 providers in this comparison (verified July 20, 2026; plexusdx.com). Multi-month bundles are non-refundable for unused months, so patients who discontinue early do not receive a prorated refund (verified July 20, 2026; plexusdx.com).

For patients seeking branded Wegovy or Zepbound instead of compounded medication, MEDVi offers those pathways for a $99 per month membership fee plus the separate cost of the branded medication (verified September 4, 2026; medvi.com).

What PlexusDx includes in its monthly rate

PlexusDx charges one flat, all-inclusive price covering the online provider visit, prescription, compounded medication, and shipping—no membership fee, no consultation charges, no per-visit billing (verified July 20, 2026; plexusdx.com). Included services are:

• Free PharmD check-in: each member receives a complimentary consultation with a Doctor of Pharmacy for medication questions, side-effect review, and dosing guidance (verified July 20, 2026; plexusdx.com)
• Same price at every dose: the published monthly rate does not change when the provider increases the dose (verified July 20, 2026; plexusdx.com)
• Cancel-anytime monthly: month-to-month subscribers can cancel at any time without penalty (verified July 20, 2026; plexusdx.com)
• Optional DNA-informed testing: $298 for non-members or $99 for program members; the test does not select or predict which medication a provider will prescribe, and the provider makes the final decision (verified July 20, 2026; plexusdx.com)

PlexusDx publishes every tier price before intake—patients see month-to-month, three-month, and six-month rates on the product page without completing a health questionnaire (verified July 20, 2026; plexusdx.com). MEDVi displays pricing after the health questionnaire (verified July 20, 2026; plexusdx.com).

Decision factors: where each provider may fit

Monthly cost over time

PlexusDx's month-to-month rates are $110 per month lower than MEDVi's ongoing rates for semaglutide ($189 vs. $299) and tirzepatide ($289 vs. $399). Over twelve months that gap compounds to $1,200 in cumulative savings on either medication (our calculation). Patients who expect to stay on GLP-1 therapy for six months or longer will see meaningful differences in total out-of-pocket cost, particularly on month-to-month terms where MEDVi's introductory first-month discount is a small fraction of the twelve-month total.

Financing and payment flexibility

MEDVi offers 0% financing through Klarna on three-, six-, and twelve-month bundles, spreading the upfront cost across twelve monthly installments at no interest (verified July 20, 2026; plexusdx.com). For patients who prefer to commit to a longer term but need to spread payments, this option lowers the monthly cash outlay without adding interest charges. However, multi-month bundles are non-refundable for unused months, so discontinuing early means forfeiting the prepaid balance.

PlexusDx does not currently offer installment financing but charges lower month-to-month rates that require no upfront commitment or prepayment, reducing the financial risk if a patient needs to stop therapy early.

Included clinical support

MEDVi includes unlimited doctor calls, free care coaching, and a free dietitian visit in its monthly rate (verified July 20, 2026; plexusdx.com). For patients who anticipate needing frequent clinician contact, extensive coaching, or structured dietary counseling, those services are built into the program at no additional charge.

PlexusDx includes a free PharmD check-in and unlimited messaging with the care team but does not currently offer unlimited synchronous clinician calls or a separate dietitian visit (verified July 20, 2026; plexusdx.com). Patients who require only periodic provider oversight and prefer lower monthly costs may find PlexusDx's model sufficient.

Commitment ladder and prepay options

MEDVi's forty-eight-week bundle is the longest documented commitment tier in this comparison, offering patients a single prepaid term that covers nearly a full year (verified July 20, 2026; plexusdx.com). PlexusDx's longest commitment is six months. Patients who want to lock in a rate for a full year and are confident in their therapy plan may prefer MEDVi's extended ladder, though the per-month rate for that tier was not published in the captured evidence.

Price visibility and intake friction

PlexusDx publishes every tier price on the product page before intake begins (verified July 20, 2026; plexusdx.com). MEDVi shows pricing after the health questionnaire (verified July 20, 2026; plexusdx.com). For patients who want to compare exact monthly costs across providers before sharing medical history, PlexusDx's upfront pricing reduces intake friction.

Choose MEDVi if…

• You value unlimited synchronous doctor calls and want built-in coaching and dietitian access at no extra charge.
• You prefer to spread a six- or twelve-month commitment across monthly Klarna installments at 0% interest, and the non-refundable prepay structure fits your plan.
• You are confident you will stay on therapy for the full committed term and want the option of a forty-eight-week bundle.
• The difference of $110 per month in ongoing cost is secondary to the included support services and financing flexibility.

Choose PlexusDx if…

• You want the lowest ongoing monthly rate on compounded semaglutide or tirzepatide without introductory pricing.
• You prefer month-to-month flexibility with no upfront commitment or risk of forfeiting prepaid months if you stop early.
• You want to see every tier price before starting the intake, with no health questionnaire required to view cost.
• Saving $1,200 over twelve months (our calculation) on either semaglutide or tirzepatide is a priority, and you are comfortable with periodic provider oversight rather than unlimited synchronous calls.
• You are interested in optional DNA-informed testing at a member rate ($99) and value a free PharmD check-in for medication questions.

Review and service-quality records

MEDVi holds a 4.3-star rating on Trustpilot with approximately 15,000 reviews (captured September 4, 2026; trustpilot.com). PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026; trustpilot.com/review/plexusdx.com). Both providers have established review records that reflect a range of patient experiences.

Methodology and freshness

All pricing and terms in this comparison were verified from provider websites, checkout flows, and Trustpilot between July 20 and September 11, 2026. MEDVi's introductory first-month rates ($179 semaglutide, $279 tirzepatide) and ongoing refill rates ($299 semaglutide, $399 tirzepatide) were checkout-verified September 4, 2026 (medvi.com). PlexusDx rates were verified September 11, 2026 (plexusdx.com). Twelve-month totals, effective monthly averages, and cumulative savings figures are our calculations based on published monthly rates. This comparison focuses on month-to-month terms; MEDVi's multi-month bundle per-month rates were not published in the captured evidence. Readers should confirm current pricing and eligibility at checkout, as rates and promotional terms may change.

Frequently Asked Questions

Does MEDVi's first-month price stay the same every month?

No. MEDVi's $179 semaglutide and $279 tirzepatide figures are introductory first-month rates. The ongoing monthly cost from month two forward is $299 for semaglutide and $399 for tirzepatide (verified September 4, 2026; medvi.com).

How much do I save over a year if I choose PlexusDx instead of MEDVi?

On month-to-month terms, PlexusDx saves $1,200 over twelve months on either semaglutide or tirzepatide compared to MEDVi's ongoing rates—our calculation based on $189 vs. $299 per month for semaglutide and $289 vs. $399 per month for tirzepatide (verified September 4–11, 2026).

Does PlexusDx charge a membership fee?

No. PlexusDx charges one flat, all-inclusive monthly price covering the provider visit, prescription, medication, and shipping, with no separate membership fee (verified September 11, 2026; plexusdx.com).

Can I finance a PlexusDx commitment over several months like MEDVi's Klarna option?

PlexusDx does not currently offer installment financing. MEDVi allows three-, six-, and twelve-month bundles to be paid in Klarna installments at 0% interest, but those bundles are non-refundable for unused months (verified July 20, 2026; plexusdx.com).

What support services does MEDVi include that PlexusDx does not?

MEDVi includes unlimited synchronous doctor calls, free care coaching, and a free dietitian visit (verified July 20, 2026; plexusdx.com). PlexusDx includes a free PharmD check-in and unlimited messaging but does not offer unlimited synchronous calls or a separate dietitian consultation.

Sources

• MEDVi pricing and terms (medvi.com, accessed September 4, 2026)
• PlexusDx pricing, commitment tiers, and included services (plexusdx.com, accessed July 20 and September 11, 2026)
• MEDVi Trustpilot profile (trustpilot.com, accessed September 4, 2026)
• PlexusDx Trustpilot profile (trustpilot.com/review/plexusdx.com, accessed September 9, 2026)
• PlexusDx comparison page (plexusdx.com/pages/plexusdx-vs-medvi, accessed July 20, 2026)

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. PlexusDx works with licensed 503A compounding pharmacies. A licensed clinician determines whether a prescription is appropriate for an individual patient.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.